Summary Conditioned media from 14 short term fibroblast cell lines were mitogenic for human breast cancer cells with different steroid receptor profiles in serum-free culture. Fibroblast-conditioned medium stimulated tritiated thymidine incorporation in short term culture and growth in a longer proliferation study as measured by the MTT colourimetric assay.
There is evidence for autocrine control of human breast cancer growth, through endogenous or oestrogen controlled production of polypeptide growth factors (Lippman et al., 1986a; 1986b; Cullen et al., 1989) . It has also been proposed that paracrine interactions between stromal tissue and malignant epithelia play an important role in the development and control of human breast cancer (Lippman et al., 1986a; 1986b; Cullen et al., 1989) . Human breast cancer cells have been shown to express growth factors for mesenchymal cells (Rozengurt et al., 1985; Peres et al., 1987) , suggesting a molecular basis for the generation of tumour stroma. There is controversy however as to whether neighbouring stromal tissue cells secrete soluble factors that regulate the growth of malignant epithelia (Yee et al., 1988; Cullen et al., 1991; Clarke et al., 1992) . Although studies have demonstrated that fibroblasts increased the growth of human breast cancer cells, the evidence remains inconclusive as to the extent and nature of the paracrine stimulation.
This laboratory and others (Camps et al., 1990) have reported that co-inoculation of human breast cancer cells and fibroblasts increased both the 'take' and size of xenotransplants in athymic mice. Fibroblasts that had been pre-treated with glutaraldehyde increased MCF-7 tumour take but not growth , whereas lethally irradiated fibroblasts (Picard et al., 1986; Camps et al., 1990) and fibroblast-conditioned medium (Picard et al., 1986) stimulated tumour growth, though to a lesser extent than live fibroblasts. This suggests that tumour take is induced by an inert fibroblast factor, whereas maximal growth stimulation of malignant epithelia required the continuous supply of a tumour promoting factor by the interacting fibroblasts.
Studies of the influence of breast fibroblasts on the growth of breast cancer cells in vitro, have provided conflicting results. Mukaida et al. (1991) demonstrated that fibroblasts from mammary gland tissue increased the growth of MCF-7 cells when co-cultured in double layer soft agar. However, conditioned medium from these fibroblasts failed to stimulate MCF-7 cell growth in both anchorage independent and anchorage dependent growth assays. Adams et al. (1988a) demonstrated that conditioned medium from fibroblasts derived from malignant and benign breast tumours increased the growth of the human breast cancer cell line MCF-7 in vitro. As they used a serum based culture system, interaction between growth factors in the serum and proteins in the conditioned medium may be responsible for the stimulation in breast cancer cell growth. This laboratory (Ryan et al., 1991) and others (Van Roozendaal et al., 1992) have demonstrated that fibroblast-conditioned medium stimulates breast cancer cell growth in serum free culture, indicating the production of a mitogenic factor by human fibroblasts.
In this paper, we investigate the importance of fibroblast derived products in paracrine stimulation of human breast cancer cells in vitro using a serum free assay system. We compare the mitogenic activity of fibroblast-conditioned medium with that of both benign and malignant epithelia and endothelium. Finally, we investigate the characteristics of the factor or factors present in fibroblast-conditioned medium that are mitogenic for human breast cancer cells in vitro.
Materials and methods
All chemicals were supplied by Sigma Chemical Co, Dorset, UK. Except where specifically noted.
Tissue culture media The basic tissue culture media used throughout was DMEM/ F12 1: l(phenol red free) supplemented with 15 mM HEPES, 2.2 g 1i sodium bicarbonate and the antibiotics Benzylpenicillin (Glaxo Lab Ltd, Greenford UK) 50 units ml-', Streptomycin (Evans Medical Ltd, Greenford UK) 100 tLg ml-' and Amphotericin B (Squibb, Hounslow, UK) 2 pg ml-'. This is referred to as serum free medium (SFM).
For routine maintenance of fibroblasts and the breast cancer cell lines SFM was supplemented with human monocomponent insulin 0.12 iu ml-' (Novo Industries, Romford, UK), hydrocortisone 4 jig ml-' (Upjohn Ltd, Crawley, UK) and 10% Fetal Calf Serum (FCS) (Gibco Ltd, Paisley, UK) referred to as complete medium (CM). Non malignant breast epithelia were maintained in CM further supplemented with cholera toxin (10 ng ml-') and epidermal growth factor (EGF) (I0 ng ml-').
The malignant breast cell lines were grown in basal medium containing dextran/charcoal stripped 10% FCS (DCC-CM) for 48 h prior to growth assays. The cells were grown in serum free medium supplemented with BSA (200 tLg ml-') and transferrin (10glg ml-') (SFM-BSA/Tf) during proliferation assays.
Primary cultures of breast fibroblasts and epithelia Samples of breast tissue and a wound biopsy were dissected free of fat and cut into small (1-5 mm) pieces.
The dissected tissue was subjected to collagenase digestion (0.5 mg ml-' collagenase) and the samples mixed overnight on a blood wheel at 37'C. The digest was centrifuged, 5 Cell proliferation was measured using a colourimetric assay (Mossman, 1983) based on the ability of viable cells to convert a soluble tetrazolium salt, 3,[4,5-Dimethylthiazol-2-yl]-2,5,-diphenyltetrazolium bromide (MTT) into an insoluble formazan precipitate. Following initial calibration experiments, the assay was modified from the procedure of Twentyman and Luscombe (1987) . Twenty jil MTT (2.5 mg ml-' Phosphate Buffered Saline pH 7.2) was added for 4 h and all medium was removed leaving purple crystals of insoluble tetrazolium at the bottom of the wells. The crystals were redissolved by the addition of 200 slI DMSO and the absorbance was measured in a Titertek multiwell spectrophotometer at 550 nm.
Tritiated thymidine assay Cells were grown for 20 h, following which, 3[H]-thymidine (Amersham UK plc) was diluted in thymidine containing medium and added to each well at a final concentration of 2 tici ml-' for a period of 8 h. Subsequently the medium was removed, the cells incubated for 15min in ice cold 10% TCA, washed three times in 5% TCA for 5 min, lysed overnight in 0.5 M NaOH and the incorporated radioactivity quantified by scintillation counting.
Characterisation of the mitogenic component in fibroblast-conditioned medium Heat stability Conditioned medium was heated to 56°C and 100°C for 30 min and the stimulatory activity tested on MCF-7 cells.
Trypsin sensitivity
Trypsin at a concentration of 1Olg ml-' was added to fibroblast-conditioned medium and incubated for 1 h at 37°C. The effect of the trypsin was neutralised by the addition of soyabean trypsin inhibitor at a concentration of 20 jig ml-'.
As a control conditioned medium was incubated for 1 h with trypsin 10 tLg ml-' together with trypsin inhibitor, 20 ;tg ml -' at 37°C. Recovery of mitogenic activity following trypsin exposure was calculated as a percentage of this control.
Stability to reducing agents Dithiothreitol was added to fibroblast-conditioned medium at a final concentration of 50 mM for 1 h at room temperature, the medium was then dialysed at 4°C against three changes of SFM using Spectra/Por 3 dialysis tubing (Spectrum Medical Industries, Inc, USA) and mitogenic activity assayed.
Acid and ionic stability Fibroblast-conditioned medium was dialysed for 4 h against 1 M acetic acid and distilled water at 4°C using Spectra/Por 3 dialysis tubing (mol wt cut off. 3,500) (Spectrum Medical Industries, Inc, USA). The pH of acid treated medium was demonstrated to have fallen to pH 2.0. The medium was then dialysed against SFM until the pH of the acid treated medium had returned to 7.3. Mitogenic activity was then assayed. As a control, fibroblast-conditioned medium was dialysed for 4 h against SFM and the activity recovered following dialysis against acid and distilled water calculated as a percentage of this control.
Heparin binding Twenty-five ml of fibroblast-conditioned medium was added to a 5 ml Hi-trap Heparin (Pharmacia-LKB Sweden) affinity column. The unabsorbed material was collected and the mitogenic activity compared to that of untreated conditioned medium. The column was then eluted with increasing concentrations of NaCl in 20 mM tris buffer pH 7.2. Fractions were collected and dialysed against three changes of SFM using Spectra/Por 3 dialysis tubing (Spectrum Medical Industries, Inc, USA). The mitogenic activity of each fraction was assayed.
Sephadex G-75 column Fibroblast-conditioned medium was purified using a modification of the procedure described by Adams et al. (1988b) . Fibroblast-conditioned medium was concentrated 10 fold by ultrafiltration using a YM2 filter (mol wt cut off 1000) (Amicon Ltd, UK). The concentrate was then added to a Sephadex G-75 column (1.65 cm x 65 cm). The Days in culture Comparison of conditioned medium from breast fibroblasts, benign breast epithelia, malignant breast epithelia, and endothelia Undiluted benign epithelial conditioned medium inhibited MCF-7 cell growth (28.9% P<0.01), however dilution to 50% in SFM (BSA/TF) produced a small but significant increase in MCF-7 cell growth with a 22.7% increase in MTT absorbance (P<0.01) (Figure 4 ). Malignant epithelial conditioned medium was not mitogenic, in undiluted form producing a significant inhibition of MCF-7 cells (11.8% P <0.05) (Figure 4 ). Similar results with malignant epithelial conditioned medium have been reported (Van der Burg et al., 1990) . Endothelial cells were highly stimulatory, their conditioned medium causing significant increases in MTT absorbance, 98.4% (P<0.01) at a dilution of 50% in SFM (BSA/Tf) (Figure 4 ). Endothelial cells were found to be the only other cell type, beside fibroblasts to stimulate the growth of human tumours as xenotransplants in athymic mice (Picard et al., 1986) suggesting that mesenchymal cells produce mitogenic factors for human tumour cells. results concur with the report of Karey and Sirbasku (1990) and confirm that the effects of known mitogens were detectable in our assay system.
Characterisation of the mitogenic component of fibroblast-conditioned medium The effect of heat, trypsin, dithiothreitol, acid and ionic treatment on the mitogenic activity of fibroblast-conditioned medium is presented in Table II . The mitogenic component of fibroblast-conditioned medium is relatively heat and acid stable with exposure to 100°C and 1 M acetic acid reducing the activity to 38% and 48% of control levels respectively, whereas dialysis against distilled water reduces the mitogenic activity to 22%. The protein nature of the mitogenic component is confirmed by the reduction in activity to 55% following exposure to trypsin and total loss of activity following dithiothreitol treatment.
Fibroblast-conditioned medium that had been passed through a heparin column was as stimulatory as untreated conditioned medium, and the fractions collected following elution with increasing concentrations of NaCl were found to contain no stimulatory activity.
Fibroblast-conditioned medium was subjected to a crude purification on a Sephadex G-75 column. The effect of individual fractions on the growth of MCF-7 cells in SFM (BSA/Tf) is presented as MTT absorbance (Figure 6) . The values for fractions obtained from conditioned medium are shown alongside values obtained from purification of SFM. In three separate fractionations a peak of increased cell growth was detectable at fraction 14, which corresponds to a molecular weight of 8,000 Da approximately. 
Discussion
The results demonstrate that conditioned media from short term cultures of human fibroblasts are mitogenic for a number of human breast cancer cell lines, increasing both DNA synthesis in short term culture and cell number in a more long term proliferation assay. These findings support the concept that stromal cells may play an important role in the regulation of human breast tumour growth, through the production of factors that modulate the proliferation of tumour epithelia (Lippman et al., 1986a; 1986b; Yee et al., 1988; Cullen et al., 1991) . Van Roozendaal et al. (1992) , using a serum free culture system and the MTT proliferation assay, demonstrated that breast tumour cells responded differently to fibroblast-conditioned medium: the steroid receptor positive cell lines MCF-7 and ZR 75.1 were stimulated to grow, whereas the steroid receptor negative cell lines MDA-MB-231 and Evsa-T showed little or no proliferative response. We have demonstrated that fibroblast-conditioned medium increased radioactive thymidine uptake and MTT absorbance in all tested breast cancer cells.
Although it has been demonstrated that fibroblast stimulation of human breast cancer cell growth in vivo is independent of tissue source ), Mukaida et al. (1991 reported that only fibroblasts from human mammary tissue and lung stimulated MCF-7 cell growth in a double layer soft agar assay. Fibroblasts from other tissues had no effect or were inhibitory. Adams et al. (1988a) reported that fibroblasts derived from malignant and benign breast tumours produced conditioned medium that stimulated MCF-7 cell growth in vitro, whereas fibroblasts derived from reduction mammoplasty tissue were inhibitory. Van Roozendaal et al. (1992) found that all fibroblasts, regardless of tissue source, stimulated MCF-7 growth in vitro. Our data concurs with this finding. However, they reported that the extent of the proliferative response was dependent on the source of the isolated fibroblasts. Tumour and skin fibroblasts induced a greater mitogenic effect on MCF-7 cells than those isolated from benign breast tissue.
Comparison of conditioned medium from fibroblast, benign epithelial, malignant epithelial and endothelial cell cultures showed that only cells derived from mesenchymal tissues were mitogenic for MCF-7 cells.
There is little information in the literature as to the nature and identity of the factors present in fibroblast-conditioned medium that stimulate the proliferation of tumour epithelia. Characterisation of the mitogenic component of fibroblastconditioned medium demonstrates that after boiling for 30 min a residual activity of 30% remains and reduction to pH 2.0 reduces activity by half. The protein nature of the mitogenic component is suggested by the fact that it is sensitive to dithiothreitol and proteolytic enzyme treatment. The mitogenic component of fibroblast-conditioned medium has no affinity for heparin, therefore heparin binding growth factors such as basic and acidic fibroblast growth factors can be ruled out as the mitogenic factor in the conditioned medium. Partial purification of fibroblast-conditioned medium demonstrated that the cells secrete a mitogenic factor for MCF-7 cells with a molecular weight of approximately 8,000. TGF-a and the insulin like growth factors are small polypeptides with molecular weights similar to the factor identified and both factors have been shown by ourselves and others to be potent mitogens for MCF-7 cells in vitro (Karey & Sirbasku 1988 ; Van der Burg et al., 1990; Osborne et al., 1989 Osborne et al., , 1990 . However, at the neutral pH at which the fibroblastconditioned medium was extracted from the Sephadex column, IGFs would be expected to be bound to high affinity binding proteins and would elute at a much higher molecular weight. Normally, acid extraction would be required to extract free IGFs (Hintz, 1984) .
IGF-I and IGF-II have been shown to be produced by human fibroblasts in vitro (Clemmons, 1984) . In situ hybridisation studies have shown that IGF-I mRNA is expressed in the stromal tissue of breast tumours U.Z W.& s i 1's66-~ but not in the epithelial cells. Cullen et al. 1991 have demonstrated that short term cultures of fibroblasts isolated from benign tumours express high levels of IGF-I mRNA whereas fibroblasts isolated from malignant tumours express high levels of IGF-II mRNA. They also examined a panel of breast tumour cell lines (containing both oestrogen receptor positive and negative phenotypes) and breast cancer specimens. Messenger RNA encoding for IGF-I, IGF-II and Insulin receptors was present in virtually all samples tested (Cullen et al., 1990) . It has been suggested that the IGFs function as stromal derived factors that play an important role in the paracrine regulation of human breast cancer (Yee et al., 1988; Cullen et al., 1991) . Clarke et al. (1992) dispute this hypothesis. While acknowledging that stromal fibroblasts secrete IGFs, they suggest that the IGFs act as autocrine factors inducing increased fibroblast growth. They point out that IGF production must be sufficient both to saturate the IGF receptors on stromal cells and to avoid inactivation by tumour produced inhibitory insulin binding proteins .
The experiments detailed in this paper clearly demonstrate that fibroblasts secrete factors that stimulate human breast cancer in vitro. These factors may play an important role in the paracrine regulation of human breast cancer by stromal cells. Partial purification of the fibroblast-conditioned medium suggests that they secrete a non-heparin-binding peptide with a molecular weight very close to that of the IGFs and TGF-o. Further study is required to characterise or isolate fibroblast derived growth factors and to determine their role in epithelial-stromal interaction in the human breast.
